Short Summary
M/s.World Wide Brands Inc challenged the Intellectual Property Appellate Board's order allowing the registration of 'Camel Collection' by local partners trading as The Central Wearhouse. The petitioner argued that their global reputation and prior use entitled them to exclusive rights, while the respondents claimed long-standing continuous use in India since 1992. The Madras High Court upheld the appellate board's finding that the petitioner failed to provide sufficient evidence of commercial publicity within India.
Detailed Summary
M/s.World Wide Brands Inc challenged the Intellectual Property Appellate Board's order allowing the registration of 'Camel Collection' by local partners trading as The Central Wearhouse. The petitioner argued that their global reputation and prior use entitled them to exclusive rights, while the respondents claimed long-standing continuous use in India since 1992. The Madras High Court upheld the appellate board's finding that the petitioner failed to provide sufficient evidence of commercial publicity within India.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Madras High Court. Understanding the court's reasoning in M/s.World Wide Brands Inc. vs Smt.Dayavanti Jhamnadas Hinduja, Smt.Janaki Madanlal Hinduja, Smt.Veena Rajendra Hinduja, Smt.Nalini Dinesh Hinduja (Trading as The Central Wearhouse) and The Assistant Registrar of Trade Marks is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Cipla LimitedvsNovartis Ag & Anr
Cipla Limited appealed an injunction granted against it by the Delhi High Court, which restrained Cipla from using or manufacturing products containing INDACATEROL. The dispute centered on Novartis Ag & Anr's patent (No. 222346) for the drug INDACATEROL, marketed as ONBREZ. While Cipla argued that the respondents did not manufacture the drug in India and thus were not working the patent locally, the court upheld the injunction.
Alpa Laboratories LimitedvsTroikaa Pharmaceuticals Ltd And Anr.
The court heard arguments regarding the maintainability of a revocation petition filed by Alpa Laboratories Limited, which was based on the apprehension that Troikaa Pharmaceuticals Ltd would institute an infringement suit. The court directed parties to seek instructions and re-notify the matter.
Dharampal Satyapal LimitedvsMr. Raj Kumar Agarwal & Anr.
This Delhi High Court judgment confirms a settlement reached between Dharampal Satyapal Limited (Plaintiff) and Mr. Raj Kumar Agarwal & Anr. (Defendants). The parties amicably resolved the dispute over trademark infringement concerning flavored pan-masala products. Key terms include the Defendants acknowledging the Plaintiff's sole proprietary rights in 'TANSEN' and 'TANSEN BLUES,' agreeing to immediately cease using the infringing mark 'TENSION FREE,' and undertaking to destroy all related materials and withdraw associated IP registrations.
Pcm Stresscon Overseas VenturesvsPatil Rail Infrastructure Private
The plaintiffs seek an injunction against the defendant for allegedly infringing their technology and making threats regarding Patent No. 219099. The defendant agreed not to communicate against the plaintiffs during the pendency of the suit.
Interdigital Technology Corporation & Ors.vsXiaomi Corporation & Ors.
The plaintiffs filed an application before the Delhi High Court challenging an anti-suit injunction issued by the Wuhan Intermediate People's Court, which sought to restrain them from prosecuting their SEP royalty rate suit in India. The court found a clear case for granting ad interim relief.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.